Morin C L, Thompson M W, Jackson S H, Sass-Kortsak A
J Clin Invest. 1971 Sep;50(9):1961-76. doi: 10.1172/JCI106688.
10 families with cystinuria were investigated by measuring: (a) quantitative 24 hr urinary excretion of amino acids by column chromatography; (b) endogenous renal clearances of amino acids and creatinine; (c) intestinal uptake of (34)C-labeled L-cystine, L-lysine, and L-arginine using jejunal mucosal biopsies; (d) oral cystine loading tests. All four of these were studied in the probands and the first two in a large number of the family members.49 members of 8 families were found to have a regular genetic pattern as described previously by Harris, Rosenberg, and their coworkers. Clinical or biochemical differences between the homozygotes type I (recessive cystinuria) and homozygotes type II (incompletely recessive cystinuria) have not been found. Both types excreted similarly excessive amounts of cystine, lysine, arginine, and ornithine, and had high endogenous renal clearances for these four amino acids. Some homozygotes of both types had a cystine clearance higher than the glomerular filtration rate. Jejunal mucosa from both types of homozygotes exhibited near complete inability to concentrate cystine and lysine in vitro. This was also documented in vivo with oral cystine loads. The heterozygotes type I were phenotypically normal with respect to the above four measurements. The heterozygotes type II showed moderate but definite abnormalities in their urinary excretion and their renal clearances of dibasic amino acids. Of the four amino acids concerned, cystine was the most reliable marker to differentiate between the heterozygotes type II and the homozygous normals. In this study, type III cystinuria, as described by Rosenberg, was not encountered. In two additional families, double heterozygotes of genotype I/II were found. The disease affecting these is clinically and biochemically less severe than that affecting homozygotes of either type I or type II. With respect to the four parameters used in this study, the double heterozygotes type I/II have results which are intermediate between those of the homozygotes type I and II and those of the heterozygotes type II.
对10个胱氨酸尿症家庭进行了调查,检测项目包括:(a) 通过柱色谱法测定24小时氨基酸定量尿排泄量;(b) 氨基酸和肌酐的内源性肾清除率;(c) 使用空肠黏膜活检组织检测(34)C标记的L-胱氨酸、L-赖氨酸和L-精氨酸的肠道摄取情况;(d) 口服胱氨酸负荷试验。对所有先证者进行了上述四项检测,对大量家庭成员进行了前两项检测。发现8个家庭的49名成员具有如Harris、Rosenberg及其同事之前所描述的规律遗传模式。未发现纯合子I型(隐性胱氨酸尿症)和纯合子II型(不完全隐性胱氨酸尿症)之间存在临床或生化差异。两种类型均排泄出相似过量的胱氨酸、赖氨酸、精氨酸和鸟氨酸,并且这四种氨基酸的内源性肾清除率都很高。两种类型的一些纯合子的胱氨酸清除率高于肾小球滤过率。两种类型纯合子的空肠黏膜在体外几乎完全无法浓缩胱氨酸和赖氨酸。口服胱氨酸负荷试验在体内也证实了这一点。杂合子I型在上述四项检测中表型正常。杂合子II型在其二元氨基酸的尿排泄和肾清除率方面表现出中度但明确的异常。在所涉及的四种氨基酸中,胱氨酸是区分杂合子II型和纯合子正常个体的最可靠标志物。在本研究中,未遇到Rosenberg所描述的III型胱氨酸尿症。在另外两个家庭中,发现了基因型I/II的双重杂合子。影响这些个体的疾病在临床和生化方面比影响I型或II型纯合子的疾病症状较轻。就本研究中使用的四个参数而言,双重杂合子I/II型的结果介于纯合子I型和II型以及杂合子II型之间。